Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Intangibles: 2010-2024

Historic Intangibles for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Dec 2024 value amounting to $114.1 million.

  • Vanda Pharmaceuticals' Intangibles fell 6.05% to $108.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.8 million, marking a year-over-year decrease of 6.05%. This contributed to the annual value of $114.1 million for FY2024, which is 5.99% down from last year.
  • As of FY2024, Vanda Pharmaceuticals' Intangibles stood at $114.1 million, which was down 5.99% from $121.4 million recorded in FY2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Intangibles peaked at $121.4 million during FY2023, and registered a low of $18.6 million during FY2022.
  • For the 3-year period, Vanda Pharmaceuticals' Intangibles averaged around $84.7 million, with its median value being $114.1 million (2024).
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Intangibles decreased by 7.55% in 2022, and later soared by 553.75% in 2023.
  • Vanda Pharmaceuticals' Intangibles (Yearly) stood at $21.6 million in 2020, then fell by 6.86% to $20.1 million in 2021, then decreased by 7.55% to $18.6 million in 2022, then soared by 553.75% to $121.4 million in 2023, then dropped by 5.99% to $114.1 million in 2024.